The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Mirum Pharmaceuticals, Inc(NASDAQ:MIRM) 
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial ...
Website: http://www.mirumpharma.com
Founded: 2018
Full Time Employees: 67
CEO: Christopher Peetz
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Mirum Pharmaceuticals Days Payable Outstanding ttm (DPO)
Mirum Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Mirum Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Mirum Pharmaceuticals Op Cashflow Per Share ttm
Mirum Pharmaceuticals Free Cashflow Per Share ttm
Mirum Pharmaceuticals Cash Per Share ttm
Mirum Pharmaceuticals P/S ratio ttm
Mirum Pharmaceuticals (GAAP) P/E ratio ttm
Mirum Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.